Assignee
HEPAREGENIX GMBH
DE·6 granted patents·2 pending applications·9 citations·filing 2018–2023
Top patents by PatentIndex Score
8 records- 0179US11040027B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2018·Granted Jun 22, 2021·5 cites·15 claims
- 0277US11912701B2Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Feb 27, 2024·2 cites·18 claims
- 0372US11858927B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Jan 2, 2024·1 cites·19 claims
- 0470US11731968B2Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2019·Granted Aug 22, 2023·1 cites·11 claims
- 0567US12264158B2Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2023·Granted Apr 1, 2025·0 cites·7 claims
- 0663US2025228834A1Pharmaceutical composition for the treatment of colon and lung cancerHEPAREGENIX GMBH·Filed 2023·Application pending·0 cites
- 0758US12466826B23-benzoyl-1H-pyrrolo[2,3-b]pyridine derivatives as MKK4 inhibitors for treating liver diseasesHEPAREGENIX GMBH·Filed 2021·Granted Nov 11, 2025·0 cites·13 claims
- 0849US2022340561A1Heteroaryl-substituted pyrazolo-pyridine protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte deathHEPAREGENIX GMBH·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HEPAREGENIX GMBH files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →